Literature DB >> 33749516

Transcriptional regulation of telomeric repeat-containing RNA by acridine derivatives.

Shuangshuang Kang1, Jiaojiao Cao1, Meiling Zhang1, Xiaoya Li1, Qian-Liang Guo1, Huang Zeng1, Zuzhuang Wei1, Xue Gong1, Jing Wang1, Bobo Liu1, Bing Shu1,2, Xiaoli Xu3, Zhi-Shu Huang1, Ding Li1.   

Abstract

Telomere is a specialized DNA-protein complex that plays an important role in maintaining chromosomal integrity. Shelterin is a protein complex formed by six different proteins, with telomeric repeat factors 1 (TRF1) and 2 (TRF2) binding to double-strand telomeric DNA. Telomeric DNA consists of complementary G-rich and C-rich repeats, which could form G-quadruplex and intercalated motif (i-motif), respectively, during cell cycle. Its G-rich transcription product, telomeric repeat-containing RNA (TERRA), is essential for telomere stability and heterochromatin formation. After extensive screening, we found that acridine derivative 2c and acridine dimer DI26 could selectively interact with TRF1 and telomeric i-motif, respectively. Compound 2c blocked the binding of TRF1 with telomeric duplex DNA, resulting in up-regulation of TERRA. Accumulated TERRA could bind with TRF1 at its allosteric site and further destabilize its binding with telomeric DNA. In contrast, DI26 could destabilize telomeric i-motif, resulting in down-regulation of TERRA. Both compounds exhibited anti-tumour activity for A549 cells, but induced different DNA damage pathways. Compound 2c significantly suppressed tumour growth in A549 xenograft mouse model. The function of telomeric i-motif structure was first studied with a selective binding ligand, which could play an important role in regulating TERRA transcription. Our results showed that appropriate level of TERRA transcript could be important for stability of telomere, and acridine derivatives could be further developed as anti-cancer agents targeting telomere. This research increased understanding for biological roles of telomeric i-motif, TRF1 and TERRA, as potential anti-cancer drug targets.

Entities:  

Keywords:  TERRA; TRF1; acridine; cancer; i-motif; telomere

Mesh:

Substances:

Year:  2021        PMID: 33749516      PMCID: PMC8632101          DOI: 10.1080/15476286.2021.1899652

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  50 in total

Review 1.  Telomerase and cancer: time to move from a promising target to a clinical reality.

Authors:  W N Keith; T R Jeffry Evans; R M Glasspool
Journal:  J Pathol       Date:  2001-11       Impact factor: 7.996

2.  How proteins bind to DNA: target discrimination and dynamic sequence search by the telomeric protein TRF1.

Authors:  Milosz Wieczór; Jacek Czub
Journal:  Nucleic Acids Res       Date:  2017-07-27       Impact factor: 16.971

Review 3.  DNA G-quadruplexes in the human genome: detection, functions and therapeutic potential.

Authors:  Robert Hänsel-Hertsch; Marco Di Antonio; Shankar Balasubramanian
Journal:  Nat Rev Mol Cell Biol       Date:  2017-02-22       Impact factor: 94.444

4.  Interaction of Quindoline derivative with telomeric repeat-containing RNA induces telomeric DNA-damage response in cancer cells through inhibition of telomeric repeat factor 2.

Authors:  Yan Zhang; Deying Zeng; Jiaojiao Cao; Mingxue Wang; Bing Shu; Guotao Kuang; Tian-Miao Ou; Jia-Heng Tan; Lian-Quan Gu; Zhi-Shu Huang; Ding Li
Journal:  Biochim Biophys Acta Gen Subj       Date:  2017-09-21       Impact factor: 3.770

5.  Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication.

Authors:  Agnel Sfeir; Settapong T Kosiyatrakul; Dirk Hockemeyer; Sheila L MacRae; Jan Karlseder; Carl L Schildkraut; Titia de Lange
Journal:  Cell       Date:  2009-07-10       Impact factor: 41.582

Review 6.  Telomere maintenance as a target for anticancer drug discovery.

Authors:  Stephen Neidle; Gary Parkinson
Journal:  Nat Rev Drug Discov       Date:  2002-05       Impact factor: 84.694

7.  Developmentally regulated transcription of mammalian telomeres by DNA-dependent RNA polymerase II.

Authors:  Stefan Schoeftner; Maria A Blasco
Journal:  Nat Cell Biol       Date:  2007-12-23       Impact factor: 28.824

Review 8.  Telomeres-structure, function, and regulation.

Authors:  Weisi Lu; Yi Zhang; Dan Liu; Zhou Songyang; Ma Wan
Journal:  Exp Cell Res       Date:  2012-09-21       Impact factor: 3.905

9.  The N-terminal domains of TRF1 and TRF2 regulate their ability to condense telomeric DNA.

Authors:  Anaïs Poulet; Sabrina Pisano; Cendrine Faivre-Moskalenko; Bei Pei; Yannick Tauran; Zofia Haftek-Terreau; Frédéric Brunet; Yann-Vaï Le Bihan; Marie-Hélène Ledu; Fabien Montel; Nicolas Hugo; Simon Amiard; Françoise Argoul; Annie Chaboud; Eric Gilson; Marie-Josèphe Giraud-Panis
Journal:  Nucleic Acids Res       Date:  2011-12-01       Impact factor: 16.971

10.  Investigating antimalarial drug interactions of emetine dihydrochloride hydrate using CalcuSyn-based interactivity calculations.

Authors:  Holly Matthews; Jon Deakin; May Rajab; Maryam Idris-Usman; Niroshini J Nirmalan
Journal:  PLoS One       Date:  2017-03-03       Impact factor: 3.240

View more
  1 in total

Review 1.  Telomere Targeting Approaches in Cancer: Beyond Length Maintenance.

Authors:  Eleonora Vertecchi; Angela Rizzo; Erica Salvati
Journal:  Int J Mol Sci       Date:  2022-03-29       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.